Hamlet BioPharma AB publ (XSAT:HAMLET B) FCF Margin % : 0.00% (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hamlet BioPharma AB publ's Free Cash Flow for the three months ended in Mar. 2025 was kr-10.39 Mil. Hamlet BioPharma AB publ's Revenue for the three months ended in Mar. 2025 was kr0.00 Mil. Therefore, Hamlet BioPharma AB publ's FCF Margin % for the quarter that ended in Mar. 2025 was 0.00%.

As of today, Hamlet BioPharma AB publ's current FCF Yield % is -5.32%.

The historical rank and industry rank for Hamlet BioPharma AB publ's FCF Margin % or its related term are showing as below:

XSAT:HAMLET B's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -102.29
* Ranked among companies with meaningful FCF Margin % only.

Hamlet BioPharma AB publ FCF Margin % Historical Data

The historical data trend for Hamlet BioPharma AB publ's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ FCF Margin % Chart

Hamlet BioPharma AB publ Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

FCF Margin %

Get a 7-Day Free Trial

Hamlet BioPharma AB publ Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Hamlet BioPharma AB publ's FCF Margin %

For the Biotechnology subindustry, Hamlet BioPharma AB publ's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hamlet BioPharma AB publ's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Hamlet BioPharma AB publ FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Hamlet BioPharma AB publ's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-36.28	/	0
	=	%

Hamlet BioPharma AB publ's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	-10.389	/	0
	=	%

Hamlet BioPharma AB publ FCF Margin % Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamlet BioPharma AB publ Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

7ZT:Germany

Address

Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42

Website

http://www.hamletpharma.com

Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines